Clinical bottom line
Nutritional ketogenic diets (NKDs) are gaining attention as a potential adjunctive therapy in palliative care for symptom management, particularly in patients with advanced cancer. While preliminary evidence suggests potential benefits in symptom relief and quality of life, the integration of NKDs into palliative care requires careful consideration of individual patient needs and existing comorbidities. Clinicians should be aware of the current evidence, uncertainties, and practical implications before recommending NKDs.
What the evidence shows
Recent studies have explored the role of NKDs in managing symptoms such as pain, fatigue, and cognitive dysfunction in palliative care settings. A systematic review by Klement and Champ (2014) highlighted the potential of ketogenic diets to improve metabolic health and reduce tumor growth, which may contribute to symptom relief in cancer patients (PMID: 24859438). More recent research by Weber et al. (2019) found that NKDs could lead to improvements in quality of life and physical functioning in patients with advanced cancer, though the study emphasized the need for further research to confirm these findings (PMID: 31006536).
A pilot study by Schmidt et al. (2020) investigated the effects of NKDs on fatigue and quality of life in patients with glioblastoma, reporting a reduction in fatigue and an improvement in overall well-being (PMID: 31940281). These findings suggest that NKDs may offer a supportive role in managing certain symptoms in palliative care, although the evidence remains preliminary and requires validation through larger, controlled trials.
Caveats and uncertainty
While the potential benefits of NKDs in palliative care are promising, several caveats and uncertainties must be considered. The evidence base is still limited, with most studies being small-scale or pilot in nature. Additionally, the long-term effects and safety of NKDs in palliative care populations are not well understood, particularly in patients with complex medical conditions.
Patient adherence to NKDs can be challenging due to dietary restrictions and potential side effects such as gastrointestinal discomfort and nutrient deficiencies. Furthermore, the impact of NKDs on specific symptoms and overall survival remains unclear, necessitating cautious interpretation of current findings.
How this may change practice
If further validated, NKDs could become a valuable component of multimodal symptom management strategies in palliative care. Clinicians should consider the potential benefits of NKDs for symptom relief in patients with advanced cancer, while also weighing the dietary challenges and individual patient factors. Collaborative care involving dietitians and nutritionists may enhance the feasibility and effectiveness of NKDs in clinical practice.
Clinicians should remain informed about ongoing research and emerging evidence to make evidence-based recommendations. Until more robust data are available, NKDs should be considered on a case-by-case basis, with careful monitoring of patient outcomes and potential adverse effects.